,Set,NGenes,Direction,PValue,FDR
1,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,8.83465301537091e-06,0.00726208477863488
2,WP_IRON_METABOLISM_DISORDERS,13,Down,0.000174849099086693,0.0718629797246307
3,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.000367685498344963,0.0858661608486729
4,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.000417840198776997,0.0858661608486729
5,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.000688645358080011,0.113213296868354
6,WP_NUCLEOTIDE_GPCRS,5,Up,0.00302097367920655,0.406338468557313
7,WP_MONOAMINE_GPCRS,3,Up,0.00365698697949699,0.406338468557313
8,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.00395463229739478,0.406338468557313
9,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.00500253095634811,0.446959228818652
10,WP_IRON_METABOLISM_IN_PLACENTA,10,Down,0.00628619279036555,0.446959228818652
11,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.00663554972665692,0.446959228818652
12,WP_PROSTAGLANDIN_SIGNALING,23,Up,0.00715622314261512,0.446959228818652
13,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Up,0.00762409214083454,0.446959228818652
14,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Up,0.00790536894073628,0.446959228818652
15,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Up,0.00819584042624467,0.446959228818652
16,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Up,0.00869993632737035,0.446959228818652
17,WP_IL3_SIGNALING,46,Up,0.0114026858247777,0.5426095121715
18,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0118819601205438,0.5426095121715
19,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.0146667054083698,0.609661817386123
20,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.0158406334049729,0.609661817386123
21,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.0158992505247005,0.609661817386123
22,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.0163169829470738,0.609661817386123
23,WP_PURINERGIC_SIGNALING,14,Up,0.0181193430359618,0.647569564154808
24,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.023135034652616,0.792374936852096
25,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.0257466259277282,0.827572993757498
26,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Down,0.0307785192313719,0.827572993757498
27,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.0325077827665655,0.827572993757498
28,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Up,0.0350346264367928,0.827572993757498
29,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0355313177577274,0.827572993757498
30,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Up,0.0355501018742232,0.827572993757498
31,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.0359606937267223,0.827572993757498
32,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.0362122822642405,0.827572993757498
33,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.0398921677544823,0.827572993757498
34,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.0405586550161808,0.827572993757498
35,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.0419492406188974,0.827572993757498
36,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.0421204239724219,0.827572993757498
37,WP_MALE_INFERTILITY,69,Down,0.0434847733276975,0.827572993757498
38,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Up,0.0437957456352624,0.827572993757498
39,WP_FERROPTOSIS,51,Down,0.0441979718754242,0.827572993757498
40,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.0456295330616045,0.827572993757498
41,WP_VALPROIC_ACID_PATHWAY,8,Up,0.0456535024771969,0.827572993757498
42,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.045738844387132,0.827572993757498
43,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.0466209047295419,0.827572993757498
44,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Up,0.0469379276418531,0.827572993757498
45,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.0481262257083458,0.827572993757498
46,WP_BLOOD_CLOTTING_CASCADE,7,Up,0.0485722260949637,0.827572993757498
47,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,16,Up,0.0489649001827389,0.827572993757498
48,WP_ANGIOGENESIS,14,Down,0.0494409352945324,0.827572993757498
49,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Up,0.0509962712727689,0.827572993757498
50,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.0517889880103023,0.827572993757498
51,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.0518024310301524,0.827572993757498
52,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Up,0.0523525494834427,0.827572993757498
53,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.053529373593878,0.830210284795617
54,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.0554219619440256,0.842984494411495
55,WP_COMPLEMENT_ACTIVATION,13,Down,0.0587017697764291,0.842984494411495
56,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.0592478378964971,0.842984494411495
57,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.0595763059435752,0.842984494411495
58,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Up,0.0606570946467279,0.842984494411495
59,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.0646692898905831,0.842984494411495
60,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.0647385526681034,0.842984494411495
61,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Down,0.0657270162230215,0.842984494411495
62,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.065890356082364,0.842984494411495
63,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Up,0.0691156349751066,0.842984494411495
64,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.0697617602721702,0.842984494411495
65,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0701625438563701,0.842984494411495
66,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Up,0.0743406523798588,0.842984494411495
67,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.0744926165901801,0.842984494411495
68,WP_DRAVET_SYNDROME,13,Down,0.0765389045682673,0.842984494411495
69,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.076587603932843,0.842984494411495
70,WP_NEPHROGENESIS,4,Up,0.0770854337993901,0.842984494411495
71,WP_OXIDATIVE_DAMAGE_RESPONSE,35,Down,0.0784494280328653,0.842984494411495
72,WP_MAPK_SIGNALING,163,Up,0.0787791976058165,0.842984494411495
73,WP_IL1_SIGNALING,53,Up,0.079484212727903,0.842984494411495
74,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.0798491287935656,0.842984494411495
75,WP_RAC1PAK1P38MMP2_PATHWAY,50,Up,0.0810572481217867,0.842984494411495
76,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Up,0.0813350789789034,0.842984494411495
77,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.0842368518600378,0.842984494411495
78,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.0848907513866326,0.842984494411495
79,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.0855108211282698,0.842984494411495
80,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.0879153386491463,0.842984494411495
81,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.0883889051826369,0.842984494411495
82,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Down,0.0892915894654591,0.842984494411495
83,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Up,0.0896215660865995,0.842984494411495
84,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.0897560463844177,0.842984494411495
85,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Down,0.0901062375725203,0.842984494411495
86,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.0909575260321541,0.842984494411495
87,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Up,0.0921425527050184,0.842984494411495
88,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.0927950159627192,0.842984494411495
89,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.0935842394524794,0.842984494411495
90,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.0950286101207058,0.842984494411495
91,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.0951458566136915,0.842984494411495
92,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.095760552967822,0.842984494411495
93,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.0973424965934,0.842984494411495
94,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.0987525201965682,0.842984494411495
95,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.102355057567158,0.842984494411495
96,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.10264797893304,0.842984494411495
97,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Up,0.103398142444624,0.842984494411495
98,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.108377693142483,0.842984494411495
99,WP_HEME_BIOSYNTHESIS,8,Down,0.108377693142483,0.842984494411495
100,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Up,0.108607696745878,0.842984494411495
101,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.109700402473814,0.842984494411495
102,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Up,0.109889732621777,0.842984494411495
103,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.110865542362985,0.842984494411495
104,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Down,0.111321898203704,0.842984494411495
105,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.111797762825735,0.842984494411495
106,WP_CREATINE_PATHWAY,2,Up,0.112695832229458,0.842984494411495
107,WP_TNFALPHA_SIGNALING,85,Up,0.112971470332708,0.842984494411495
108,WP_NRXN1_DELETION_SYNDROME,2,Down,0.11384034366634,0.842984494411495
109,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.115859748918616,0.842984494411495
110,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Up,0.116045654916523,0.842984494411495
111,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.116123747672936,0.842984494411495
112,WP_CHEMOKINE_SIGNALING,109,Up,0.117086157873758,0.842984494411495
113,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Up,0.117127127535327,0.842984494411495
114,WP_CCL18_SIGNALING,21,Down,0.119243988551335,0.842984494411495
115,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.119858271882471,0.842984494411495
116,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.119862507586557,0.842984494411495
117,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Up,0.121019077199068,0.842984494411495
118,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.121153077886438,0.842984494411495
119,WP_CYTOSINE_METHYLATION,7,Down,0.122851984917556,0.842984494411495
120,WP_BREAST_CANCER_PATHWAY,87,Down,0.123063429841094,0.842984494411495
121,WP_MEASLES_VIRUS_INFECTION,102,Up,0.127427250371549,0.855850685198129
122,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Down,0.127705924173302,0.855850685198129
123,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.130150011558802,0.855850685198129
124,WP_13Q1212_COPY_NUMBER_VARIATION,21,Up,0.130845869216671,0.855850685198129
125,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.134021616255428,0.855850685198129
126,WP_IDO_METABOLIC_PATHWAY,8,Up,0.135217715539757,0.855850685198129
127,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.135682693304911,0.855850685198129
128,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.136987891990712,0.855850685198129
129,WP_NEURAL_CREST_DIFFERENTIATION,40,Down,0.137723479766929,0.855850685198129
130,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.143563403893963,0.855850685198129
131,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.145675012642939,0.855850685198129
132,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.145698268908494,0.855850685198129
133,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.145766773915476,0.855850685198129
134,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Up,0.145989300376311,0.855850685198129
135,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.146189750528181,0.855850685198129
136,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Up,0.149071378187315,0.855850685198129
137,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.150362131258455,0.855850685198129
138,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.150605401222467,0.855850685198129
139,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Up,0.151761829840932,0.855850685198129
140,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Down,0.153840250130359,0.855850685198129
141,WP_15Q25_COPY_NUMBER_VARIATION,27,Down,0.155986408583516,0.855850685198129
142,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.156808135093121,0.855850685198129
143,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.156891583095153,0.855850685198129
144,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.15732734701213,0.855850685198129
145,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Down,0.157841120042629,0.855850685198129
146,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,21,Up,0.162489852663768,0.855850685198129
147,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Down,0.16253026903826,0.855850685198129
148,WP_BENZOAPYRENE_METABOLISM,5,Down,0.162790788094676,0.855850685198129
149,WP_KREBS_CYCLE_DISORDERS,11,Up,0.163833379852149,0.855850685198129
150,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.16461228461201,0.855850685198129
151,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.164901598504364,0.855850685198129
152,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.165307277319467,0.855850685198129
153,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Up,0.165623314652236,0.855850685198129
154,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.165892763191838,0.855850685198129
155,WP_NRF2ARE_REGULATION,20,Up,0.166334630720872,0.855850685198129
156,WP_HUNGER_AND_SATIETY,2,Up,0.166786844427066,0.855850685198129
157,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.167066602757616,0.855850685198129
158,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.170276736889838,0.855850685198129
159,WP_OREXIN_RECEPTOR_PATHWAY,120,Up,0.17109822883941,0.855850685198129
160,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.171859556963184,0.855850685198129
161,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.172439691326994,0.855850685198129
162,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.17272553800234,0.855850685198129
163,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,13,Up,0.173957053530226,0.855850685198129
164,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Up,0.175286248019414,0.855850685198129
165,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.177211447012361,0.855850685198129
166,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.17741052374518,0.855850685198129
167,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.179265027262301,0.855850685198129
168,WP_COMPLEMENT_SYSTEM,52,Down,0.181494293355279,0.855850685198129
169,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.182799630095127,0.855850685198129
170,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.183559966038168,0.855850685198129
171,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.186254094520346,0.855850685198129
172,WP_RETINOL_METABOLISM,6,Up,0.188072018820341,0.855850685198129
173,WP_WNT_SIGNALING_WP428,60,Down,0.188799787194115,0.855850685198129
174,WP_RANKLRANK_SIGNALING,48,Up,0.188938626717371,0.855850685198129
175,WP_G13_SIGNALING,29,Up,0.191996384463334,0.855850685198129
176,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.192509718823088,0.855850685198129
177,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Down,0.194557026729462,0.855850685198129
178,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.194934010140589,0.855850685198129
179,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.196483687778485,0.855850685198129
180,WP_NOTCH_SIGNALING_WP268,36,Up,0.198894998379197,0.855850685198129
181,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Up,0.198965189976391,0.855850685198129
182,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.201308582937872,0.855850685198129
183,WP_ASPIRIN_AND_MIRNAS,8,Down,0.205026980575971,0.855850685198129
184,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.205453692081009,0.855850685198129
185,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.20638965595109,0.855850685198129
186,WP_PYRIMIDINE_METABOLISM,71,Down,0.208202304459446,0.855850685198129
187,WP_AGERAGE_PATHWAY,54,Up,0.208731089159844,0.855850685198129
188,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.209381791189796,0.855850685198129
189,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.20939657714608,0.855850685198129
190,WP_ZINC_HOMEOSTASIS,24,Down,0.209426232682045,0.855850685198129
191,WP_NPHP1_DELETION_SYNDROME,10,Up,0.209611875614908,0.855850685198129
192,WP_OPIOID_RECEPTOR_PATHWAYS,26,Up,0.209692198167928,0.855850685198129
193,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Up,0.210181456052883,0.855850685198129
194,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,23,Up,0.211145639769019,0.855850685198129
195,WP_TYPE_II_DIABETES_MELLITUS,14,Up,0.211354106073533,0.855850685198129
196,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.213562599284769,0.855850685198129
197,WP_OSTEOCLAST_SIGNALING,9,Down,0.214548381807697,0.855850685198129
198,WP_FOCAL_ADHESION,118,Up,0.215804816834779,0.855850685198129
199,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.216274688426463,0.855850685198129
200,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.218294830199825,0.855850685198129
201,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.218706343408942,0.855850685198129
202,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Down,0.21922789020223,0.855850685198129
203,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.22095018424127,0.855850685198129
204,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.221365862981639,0.855850685198129
205,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.221570749636829,0.855850685198129
206,WP_KALLMANN_SYNDROME,11,Down,0.222009941940082,0.855850685198129
207,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.223268790384668,0.855850685198129
208,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,40,Up,0.224151869045693,0.855850685198129
209,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Up,0.224582600117747,0.855850685198129
210,WP_VEGFAVEGFR2_SIGNALING,341,Up,0.225775267688455,0.855850685198129
211,WP_TAMOXIFEN_METABOLISM,2,Down,0.226314473677212,0.855850685198129
212,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.226815403703953,0.855850685198129
213,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.227229509811705,0.855850685198129
214,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.227451573420375,0.855850685198129
215,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.227649723770453,0.855850685198129
216,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.229035055214073,0.855850685198129
217,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Up,0.229382325696836,0.855850685198129
218,WP_ATR_SIGNALING,10,Down,0.231319560735324,0.855850685198129
219,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.232520226285052,0.855850685198129
220,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.232752686960753,0.855850685198129
221,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.235880329015303,0.855850685198129
222,WP_OSTEOBLAST_SIGNALING,3,Down,0.238785752479555,0.855850685198129
223,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.239289851344441,0.855850685198129
224,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.239432498264528,0.855850685198129
225,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.239470340778023,0.855850685198129
226,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.239709635790235,0.855850685198129
227,WP_TRANSLATION_FACTORS,49,Up,0.240378701152455,0.855850685198129
228,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.241317183524289,0.855850685198129
229,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.24184432294518,0.855850685198129
230,WP_RETT_SYNDROME,30,Up,0.241882723045804,0.855850685198129
231,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Up,0.243041196378102,0.855850685198129
232,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.243200525647757,0.855850685198129
233,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.24416031665734,0.855850685198129
234,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.244444377787523,0.855850685198129
235,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.24482398648994,0.855850685198129
236,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.245884640431872,0.855850685198129
237,WP_PURINE_METABOLISM,10,Down,0.246759869089972,0.855850685198129
238,WP_HEPATITIS_B_INFECTION,116,Up,0.249339601612689,0.859017357741356
239,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.249762954379786,0.859017357741356
240,WP_DNA_DAMAGE_RESPONSE,59,Down,0.250868049151635,0.859022260599675
241,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.251941140105276,0.859022260599675
242,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.258894172243732,0.859022260599675
243,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.25950347266153,0.859022260599675
244,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Down,0.262561007851538,0.859022260599675
245,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.262942080847627,0.859022260599675
246,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.263622521350227,0.859022260599675
247,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.264974351595074,0.859022260599675
248,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.265560635882221,0.859022260599675
249,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.268617594364412,0.859022260599675
250,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.269224766066653,0.859022260599675
251,WP_DNA_REPLICATION,35,Down,0.270878933418779,0.859022260599675
252,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.271513635306108,0.859022260599675
253,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.271924109731337,0.859022260599675
254,WP_TP53_NETWORK,16,Down,0.274707759353939,0.859022260599675
255,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.275044269567758,0.859022260599675
256,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.27748722153877,0.859022260599675
257,WP_ARYLAMINE_METABOLISM,1,Down,0.277807556182889,0.859022260599675
258,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.279832013082875,0.859022260599675
259,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.280331693107719,0.859022260599675
260,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.281330574310625,0.859022260599675
261,WP_CHOLESTEROL_METABOLISM,52,Down,0.282383903406363,0.859022260599675
262,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Up,0.282853654741612,0.859022260599675
263,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.28352266373571,0.859022260599675
264,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.283778151570481,0.859022260599675
265,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.284568021494397,0.859022260599675
266,WP_GLYOXYLATE_METABOLISM,5,Up,0.284723969310801,0.859022260599675
267,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.285453927282272,0.859022260599675
268,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.285639652384253,0.859022260599675
269,WP_CELL_CYCLE,95,Down,0.285785166560664,0.859022260599675
270,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Up,0.287975691338166,0.859022260599675
271,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.287982347749845,0.859022260599675
272,WP_PRION_DISEASE_PATHWAY,28,Down,0.292907428329301,0.859022260599675
273,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Up,0.294505364847185,0.859022260599675
274,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.294594806850415,0.859022260599675
275,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Up,0.294784148865544,0.859022260599675
276,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Down,0.295744903513405,0.859022260599675
277,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.29613074717329,0.859022260599675
278,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.296169093799146,0.859022260599675
279,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.296627902931028,0.859022260599675
280,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Up,0.297900831897819,0.859022260599675
281,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.298044970341082,0.859022260599675
282,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.298842418019254,0.859022260599675
283,WP_GPR40_PATHWAY,8,Up,0.300148130712719,0.859022260599675
284,WP_GASTRIN_SIGNALING,92,Up,0.301337052958997,0.859022260599675
285,WP_TCELL_RECEPTOR_SIGNALING,73,Up,0.30241200378649,0.859022260599675
286,WP_ONECARBON_METABOLISM,22,Down,0.303094071249126,0.859022260599675
287,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.303324011959315,0.859022260599675
288,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.3046387500982,0.859022260599675
289,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.30586420915255,0.859022260599675
290,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.307500074007457,0.859022260599675
291,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.308094426107227,0.859022260599675
292,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.308266121608234,0.859022260599675
293,WP_TAR_SYNDROME,44,Up,0.308280192386522,0.859022260599675
294,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.309035670228316,0.859022260599675
295,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.309791485190945,0.859022260599675
296,WP_BENZENE_METABOLISM,3,Up,0.310810709560801,0.859022260599675
297,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.312156339729418,0.859022260599675
298,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.313189367358852,0.859022260599675
299,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.313614665909169,0.859022260599675
300,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.314139119359545,0.859022260599675
301,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Up,0.314556813187959,0.859022260599675
302,WP_VITAMIN_B12_DISORDERS,9,Up,0.320646939435174,0.871013476796778
303,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Up,0.321775086038042,0.871013476796778
304,WP_TGFB_SMAD_SIGNALING,8,Up,0.322711526186834,0.871013476796778
305,WP_ENERGY_METABOLISM,41,Up,0.325525355996962,0.871013476796778
306,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.326186645433136,0.871013476796778
307,WP_ACUTE_VIRAL_MYOCARDITIS,67,Up,0.326654421397709,0.871013476796778
308,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.32686040069217,0.871013476796778
309,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.327424774124336,0.871013476796778
310,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.329757958442883,0.874027724338136
311,WP_OSTEOPONTIN_SIGNALING,11,Up,0.33068445531528,0.874027724338136
312,WP_MTHFR_DEFICIENCY,18,Down,0.332162316838558,0.874992218722468
313,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Down,0.333178302262935,0.874992218722468
314,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.335923136479024,0.87921504973438
315,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Up,0.336925475263175,0.87921504973438
316,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.340439602765483,0.885478653498353
317,WP_MELANOMA,54,Down,0.341590198939157,0.885478653498353
318,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.343270648240841,0.885478653498353
319,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.343634659934276,0.885478653498353
320,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,172,Down,0.344947224646403,0.886083183310448
321,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.346191466540961,0.8865089890862
322,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.347500350732462,0.887097168640012
323,WP_RETINOBLASTOMA_GENE_IN_CANCER,71,Down,0.352743074063379,0.895595302651159
324,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.35300836746834,0.895595302651159
325,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.357868370565365,0.900121335808171
326,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.358379967234827,0.900121335808171
327,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Up,0.36135064145076,0.900121335808171
328,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.361454826443487,0.900121335808171
329,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.361558853129532,0.900121335808171
330,WP_ID_SIGNALING,12,Down,0.362017941515717,0.900121335808171
331,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Down,0.36292009890437,0.900121335808171
332,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.363552656311816,0.900121335808171
333,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.364810102114227,0.900522234047731
334,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.367506940902843,0.903016229021597
335,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Up,0.368017562922427,0.903016229021597
336,WP_IL17_SIGNALING,25,Up,0.373370875505012,0.913425177574761
337,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.376471633995,0.918277991524896
338,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,8,Down,0.380499588018588,0.925041643455093
339,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.383151715183121,0.925041643455093
340,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Up,0.383728832443619,0.925041643455093
341,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.38595434263219,0.925041643455093
342,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.387282999471492,0.925041643455093
343,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.38808366881144,0.925041643455093
344,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.389316784542786,0.925041643455093
345,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.389316784542786,0.925041643455093
346,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Up,0.390604010138158,0.925041643455093
347,WP_ALLOGRAFT_REJECTION,52,Down,0.39142543352279,0.925041643455093
348,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.393078582012044,0.925041643455093
349,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.39503251923755,0.925041643455093
350,WP_ECTODERM_DIFFERENTIATION,77,Down,0.39781835892175,0.925041643455093
351,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.398621137806844,0.925041643455093
352,WP_SERINE_METABOLISM,5,Down,0.399248511586421,0.925041643455093
353,WP_DNA_MISMATCH_REPAIR,21,Down,0.39995326860565,0.925041643455093
354,WP_SPHINGOLIPID_PATHWAY,21,Up,0.400052762024779,0.925041643455093
355,WP_MIRNA_BIOGENESIS,6,Down,0.400662859704408,0.925041643455093
356,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.401478526503414,0.925041643455093
357,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,20,Down,0.40259541348575,0.925041643455093
358,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.403182924625918,0.925041643455093
359,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.404002372263234,0.925041643455093
360,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.40828907631513,0.929593751234348
361,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.408725882244387,0.929593751234348
362,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.409527750502828,0.929593751234348
363,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.411432708096366,0.929593751234348
364,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.412353562883951,0.929593751234348
365,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.413094519981553,0.929593751234348
366,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.416125922737667,0.929593751234348
367,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.416143412175266,0.929593751234348
368,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.421336164027276,0.929593751234348
369,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.42181315954103,0.929593751234348
370,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.422557998132362,0.929593751234348
371,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.424330329686247,0.929593751234348
372,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.424949538337429,0.929593751234348
373,WP_TRYPTOPHAN_METABOLISM,19,Up,0.425269707744577,0.929593751234348
374,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.425555727052883,0.929593751234348
375,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.428555379545351,0.929593751234348
376,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.431450171817988,0.929593751234348
377,WP_SLEEP_REGULATION,11,Down,0.432535525358403,0.929593751234348
378,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Down,0.432714487470114,0.929593751234348
379,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.433811333362982,0.929593751234348
380,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.434384479026397,0.929593751234348
381,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.435365803558589,0.929593751234348
382,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.437422338599953,0.929593751234348
383,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.438437402956045,0.929593751234348
384,WP_ENDOMETRIAL_CANCER,48,Down,0.438922661233399,0.929593751234348
385,WP_ADIPOGENESIS,87,Up,0.440704909918261,0.929593751234348
386,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.441220528757031,0.929593751234348
387,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.443993963044362,0.929593751234348
388,WP_PRIMARY_OVARIAN_INSUFFICIENCY,91,Down,0.444371938352417,0.929593751234348
389,WP_NUCLEAR_RECEPTORS,20,Up,0.445374538342327,0.929593751234348
390,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.445729738305553,0.929593751234348
391,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.446636041580041,0.929593751234348
392,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.449810076935191,0.929593751234348
393,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Down,0.451497641784774,0.929593751234348
394,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.451614196327034,0.929593751234348
395,WP_NOTCH_SIGNALING_WP61,49,Up,0.452192823236094,0.929593751234348
396,WP_FRAGILE_X_SYNDROME,83,Up,0.452265230985059,0.929593751234348
397,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Down,0.452617263850497,0.929593751234348
398,WP_IL18_SIGNALING,193,Up,0.453311828055362,0.929593751234348
399,WP_ALZHEIMERS_DISEASE,184,Up,0.457304328908387,0.929593751234348
400,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.457304328908387,0.929593751234348
401,WP_IL7_SIGNALING,23,Down,0.458831843496192,0.929593751234348
402,WP_ENDOCHONDRAL_OSSIFICATION,27,Down,0.459018162440214,0.929593751234348
403,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Down,0.459018162440214,0.929593751234348
404,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.460404800961552,0.929593751234348
405,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Up,0.461622303063298,0.929593751234348
406,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.46202314133635,0.929593751234348
407,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.462610603081951,0.929593751234348
408,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.462610603081951,0.929593751234348
409,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Up,0.462872563849234,0.929593751234348
410,WP_SMALL_LIGAND_GPCRS,7,Down,0.46366598297577,0.929593751234348
411,WP_THERMOGENESIS,73,Up,0.466566346128725,0.932337874498009
412,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.468718982104136,0.932337874498009
413,WP_SPINA_BIFIDA,10,Down,0.469363254491017,0.932337874498009
414,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Up,0.469571630221625,0.932337874498009
415,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.472231258475281,0.934055287085634
416,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.473304950878516,0.934055287085634
417,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.473845565346362,0.934055287085634
418,WP_B_CELL_RECEPTOR_SIGNALING,85,Up,0.47678046841071,0.937592212999052
419,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.481050251228942,0.938615574621552
420,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.483998108409403,0.938615574621552
421,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.484115196029585,0.938615574621552
422,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,30,Up,0.485478441025581,0.938615574621552
423,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.486302241481818,0.938615574621552
424,WP_OVARIAN_INFERTILITY,21,Down,0.486739270891418,0.938615574621552
425,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.487358499932198,0.938615574621552
426,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.490410120556755,0.938615574621552
427,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.490546424281519,0.938615574621552
428,WP_INTEGRATED_CANCER_PATHWAY,40,Down,0.492486039916921,0.938615574621552
429,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.494334131115391,0.938615574621552
430,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.494417486192933,0.938615574621552
431,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.497162082234219,0.938615574621552
432,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.497487209745036,0.938615574621552
433,WP_UROTENSINIIMEDIATED_SIGNALING,50,Up,0.497907741429713,0.938615574621552
434,WP_P38_MAPK_SIGNALING,31,Up,0.49803720064971,0.938615574621552
435,WP_LUNG_FIBROSIS,34,Up,0.498960400296843,0.938615574621552
436,WP_BASE_EXCISION_REPAIR,29,Down,0.499040253483653,0.938615574621552
437,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.501259023338247,0.938615574621552
438,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.50216430124312,0.938615574621552
439,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Up,0.502496044815655,0.938615574621552
440,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.503263680978012,0.938615574621552
441,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.503563830180176,0.938615574621552
442,WP_PDGF_PATHWAY,36,Up,0.50491818874258,0.939010749200002
443,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.506468614435623,0.939767948230434
444,WP_PPARALPHA_PATHWAY,15,Down,0.508012348745994,0.94050934835407
445,WP_AEROBIC_GLYCOLYSIS,10,Up,0.511761438859854,0.941389339255943
446,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.511761438859854,0.941389339255943
447,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.514081108445703,0.941389339255943
448,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.514438724074371,0.941389339255943
449,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.515193859923524,0.941389339255943
450,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.515359127329896,0.941389339255943
451,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.516666337112535,0.941684543473401
452,WP_KLEEFSTRA_SYNDROME,25,Up,0.519407859007204,0.944586858636995
453,WP_WNT_SIGNALING_WP363,38,Down,0.521336950034134,0.945534503043726
454,WP_MRNA_PROCESSING,124,Down,0.523635993700573,0.945534503043726
455,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.524023222368168,0.945534503043726
456,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.524530089279731,0.945534503043726
457,WP_SEROTONIN_AND_ANXIETY,6,Up,0.529316710458849,0.946617282715954
458,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.529548432399582,0.946617282715954
459,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.533141645215459,0.946617282715954
460,WP_ENDODERM_DIFFERENTIATION,82,Down,0.534255252617663,0.946617282715954
461,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Down,0.536041711664369,0.946617282715954
462,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.536265668598784,0.946617282715954
463,WP_STEROID_BIOSYNTHESIS,2,Up,0.537219612217391,0.946617282715954
464,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.539892190403453,0.946617282715954
465,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.540826081471909,0.946617282715954
466,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.542372615868787,0.946617282715954
467,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,59,Down,0.544012582143069,0.946617282715954
468,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.544786202179625,0.946617282715954
469,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.546103996860092,0.946617282715954
470,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.546616778711341,0.946617282715954
471,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.546864294893829,0.946617282715954
472,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.547101131035865,0.946617282715954
473,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.549511030491593,0.946617282715954
474,WP_CANCER_PATHWAYS,308,Down,0.552845443209418,0.946617282715954
475,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.553052528317477,0.946617282715954
476,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.553329928210238,0.946617282715954
477,WP_BARDETBIEDL_SYNDROME,65,Down,0.554565347546593,0.946617282715954
478,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.554755829741171,0.946617282715954
479,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.555584677841903,0.946617282715954
480,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.558177281562881,0.946617282715954
481,WP_FOLATE_METABOLISM,40,Down,0.558588569971297,0.946617282715954
482,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.558912181153764,0.946617282715954
483,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.559037332768747,0.946617282715954
484,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.559063207652917,0.946617282715954
485,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.559688472393322,0.946617282715954
486,WP_VITAMIN_D_METABOLISM,6,Up,0.560037570388639,0.946617282715954
487,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.560830433920523,0.946617282715954
488,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Up,0.565481668152612,0.95251215414231
489,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.567653466334339,0.95369045698612
490,WP_MEVALONATE_PATHWAY,7,Down,0.570064877927346,0.95369045698612
491,WP_MATRIX_METALLOPROTEINASES,8,Down,0.570115573057714,0.95369045698612
492,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.573291612650097,0.95369045698612
493,WP_SPINAL_CORD_INJURY,67,Up,0.57373398900886,0.95369045698612
494,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.575848143836698,0.95369045698612
495,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.577259059230682,0.95369045698612
496,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Up,0.577400364932669,0.95369045698612
497,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Up,0.577414698112902,0.95369045698612
498,WP_HEART_DEVELOPMENT,16,Down,0.578724393114305,0.95369045698612
499,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.57894347692953,0.95369045698612
500,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.581443352472395,0.955184129514608
501,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.582174268718757,0.955184129514608
502,WP_KININKALLIKREIN_PATHWAY,2,Down,0.586747835271015,0.96015617734569
503,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.589335331424549,0.96015617734569
504,WP_BDNFTRKB_SIGNALING,26,Down,0.592656534334755,0.96015617734569
505,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,37,Down,0.59279083182459,0.96015617734569
506,WP_METHYLATION_PATHWAYS,5,Up,0.596032596795163,0.96015617734569
507,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.600224402072907,0.96015617734569
508,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.603083181436999,0.96015617734569
509,WP_INSULIN_SIGNALING,129,Up,0.608020562556488,0.96015617734569
510,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.609180323478039,0.96015617734569
511,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.610076905269672,0.96015617734569
512,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Down,0.610441107751915,0.96015617734569
513,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Down,0.612470552884183,0.96015617734569
514,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.614894294485163,0.96015617734569
515,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.616603286354922,0.96015617734569
516,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.616717316242167,0.96015617734569
517,WP_ACUTE_MYELOID_LEUKEMIA,55,Down,0.617250779647457,0.96015617734569
518,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.617629201142924,0.96015617734569
519,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Down,0.618017864539663,0.96015617734569
520,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.619260582015261,0.96015617734569
521,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Up,0.619423042815808,0.96015617734569
522,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.620428612981656,0.96015617734569
523,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.622100412142771,0.96015617734569
524,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.62429066402746,0.96015617734569
525,WP_MACROPHAGE_MARKERS,9,Up,0.62457357866775,0.96015617734569
526,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.626823926089644,0.96015617734569
527,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Up,0.627420430654888,0.96015617734569
528,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.629133818569313,0.96015617734569
529,WP_GLUTATHIONE_METABOLISM,10,Up,0.630834649765984,0.96015617734569
530,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Up,0.632219678118561,0.96015617734569
531,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Up,0.632303218137041,0.96015617734569
532,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Up,0.633160334269466,0.96015617734569
533,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.634971444354044,0.96015617734569
534,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.635624282517675,0.96015617734569
535,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.635975655940902,0.96015617734569
536,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.636504247823394,0.96015617734569
537,WP_PROTEASOME_DEGRADATION,57,Down,0.640919741897881,0.96015617734569
538,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.643105043483841,0.96015617734569
539,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.643372980726319,0.96015617734569
540,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.644703546820933,0.96015617734569
541,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.645991648322176,0.96015617734569
542,WP_HIPPOYAP_SIGNALING,16,Up,0.650095199180517,0.96015617734569
543,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.650140668956791,0.96015617734569
544,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Down,0.650869084501653,0.96015617734569
545,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Up,0.651324192611276,0.96015617734569
546,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Down,0.652083341893957,0.96015617734569
547,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.652083783377594,0.96015617734569
548,WP_DOPAMINE_METABOLISM,7,Up,0.652300486299744,0.96015617734569
549,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Up,0.652602047324001,0.96015617734569
550,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Up,0.653211667096124,0.96015617734569
551,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.65389103799619,0.96015617734569
552,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.656605819844415,0.96015617734569
553,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Down,0.657209502409397,0.96015617734569
554,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.659293922876494,0.96015617734569
555,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.662374394577399,0.96015617734569
556,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.663089648702523,0.96015617734569
557,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Up,0.665464119475794,0.96015617734569
558,WP_IL26_SIGNALING,33,Up,0.667500454332827,0.96015617734569
559,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Down,0.667773669124363,0.96015617734569
560,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.668170222502727,0.96015617734569
561,WP_NETRINUNC5B_SIGNALING,36,Down,0.668352285786063,0.96015617734569
562,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.670240326262912,0.96015617734569
563,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.674594045149015,0.96015617734569
564,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.675185030239539,0.96015617734569
565,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Down,0.677370721421839,0.96015617734569
566,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.679648235317528,0.96015617734569
567,WP_IL9_SIGNALING,15,Down,0.681483312613704,0.96015617734569
568,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.684981762473918,0.96015617734569
569,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Down,0.686892705953699,0.96015617734569
570,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.687112721232839,0.96015617734569
571,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Down,0.688435168382735,0.96015617734569
572,WP_ACE_INHIBITOR_PATHWAY,3,Up,0.688671409544426,0.96015617734569
573,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.69052747843968,0.96015617734569
574,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.69148382457308,0.96015617734569
575,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Up,0.692398831331791,0.96015617734569
576,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.694591574224424,0.96015617734569
577,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.694840720519232,0.96015617734569
578,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.695255402820175,0.96015617734569
579,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.695728231809611,0.96015617734569
580,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.696249078789708,0.96015617734569
581,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.697632202421658,0.96015617734569
582,WP_SILDENAFIL_TREATMENT,11,Up,0.69764427111729,0.96015617734569
583,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.698459505657454,0.96015617734569
584,WP_MONOAMINE_TRANSPORT,12,Up,0.699119521451116,0.96015617734569
585,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.701030408680628,0.96015617734569
586,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.701734240913167,0.96015617734569
587,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.702316115320619,0.96015617734569
588,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Up,0.702915615923808,0.96015617734569
589,WP_KCNQ2RELATED_EPILEPSIES,12,Up,0.703066963201287,0.96015617734569
590,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Down,0.704001805332967,0.96015617734569
591,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.704588077121728,0.96015617734569
592,WP_GLUCURONIDATION,7,Up,0.705317462539802,0.96015617734569
593,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.705537347110792,0.96015617734569
594,WP_IL6_SIGNALING,40,Down,0.705879395437369,0.96015617734569
595,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.710581545918378,0.96015617734569
596,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.712880433587165,0.96015617734569
597,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.712998297340621,0.96015617734569
598,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.715019932972121,0.96015617734569
599,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.715076561405314,0.96015617734569
600,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.715212784018523,0.96015617734569
601,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.716102431200003,0.96015617734569
602,WP_CILIOPATHIES,127,Up,0.717495901089216,0.96015617734569
603,WP_JOUBERT_SYNDROME,70,Up,0.722043101608927,0.96015617734569
604,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.72213178530685,0.96015617734569
605,WP_LEPTIN_SIGNALING,69,Up,0.722182601934565,0.96015617734569
606,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Down,0.722739421273335,0.96015617734569
607,WP_RAS_SIGNALING,116,Up,0.723280538453399,0.96015617734569
608,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Up,0.724915135097894,0.96015617734569
609,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.725175134503412,0.96015617734569
610,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.727059279208789,0.96015617734569
611,WP_METABOLIC_EPILEPTIC_DISORDERS,56,Up,0.727600055672062,0.96015617734569
612,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.729434115928301,0.96015617734569
613,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Up,0.729607649192002,0.96015617734569
614,WP_NONSMALL_CELL_LUNG_CANCER,59,Down,0.730478032860711,0.96015617734569
615,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Up,0.732129479693134,0.96015617734569
616,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.732899766691351,0.96015617734569
617,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.73386662944107,0.96015617734569
618,WP_CORI_CYCLE,11,Up,0.734183144250665,0.96015617734569
619,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Up,0.734884467580332,0.96015617734569
620,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.735784496802002,0.96015617734569
621,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.73607394983344,0.96015617734569
622,WP_G_PROTEIN_SIGNALING,61,Down,0.737406543714464,0.96015617734569
623,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.737412452380689,0.96015617734569
624,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Down,0.73822443128013,0.96015617734569
625,WP_EGFEGFR_SIGNALING,138,Up,0.738543303020844,0.96015617734569
626,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.740524769159163,0.96015617734569
627,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.74105434617705,0.96015617734569
628,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Up,0.741873745758196,0.96015617734569
629,WP_CILIARY_LANDSCAPE,184,Up,0.742010425058186,0.96015617734569
630,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.743497326057969,0.96015617734569
631,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.744791118195108,0.96015617734569
632,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.745166729168928,0.96015617734569
633,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.745303624839405,0.96015617734569
634,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.745446354318232,0.96015617734569
635,WP_IL11_SIGNALING,40,Up,0.746036111701002,0.96015617734569
636,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.746991674350974,0.96015617734569
637,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.749978994559953,0.96015617734569
638,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.750004042701533,0.96015617734569
639,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.750168429805202,0.96015617734569
640,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.750657080887444,0.96015617734569
641,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.751385548195898,0.96015617734569
642,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.752316482988282,0.96015617734569
643,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Up,0.752658671293948,0.96015617734569
644,WP_FOXA2_PATHWAY,9,Down,0.754804194000618,0.96015617734569
645,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.755106870105497,0.96015617734569
646,WP_PREIMPLANTATION_EMBRYO,20,Up,0.757376233652629,0.96015617734569
647,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.760515328145754,0.96015617734569
648,WP_COMPLEMENT_AND_COAGULATION_CASCADES,27,Up,0.760539840289888,0.96015617734569
649,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,27,Up,0.760539840289888,0.96015617734569
650,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.761522931136949,0.96015617734569
651,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.762585436959175,0.96015617734569
652,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.76370633676089,0.96015617734569
653,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.764915288646618,0.96015617734569
654,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.765450365824875,0.96015617734569
655,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.767242722045976,0.96015617734569
656,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Down,0.767422112879931,0.96015617734569
657,WP_FOXP3_IN_COVID19,10,Down,0.767424097951482,0.96015617734569
658,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.769384150729038,0.961145549998889
659,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.771190358334245,0.961940022080045
660,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Up,0.773786538951456,0.96233780102094
661,WP_GPCRS_CLASS_A_RHODOPSINLIKE,44,Up,0.775348024169552,0.96233780102094
662,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.777518877302815,0.96233780102094
663,WP_HISTONE_MODIFICATIONS,37,Up,0.777721870352538,0.96233780102094
664,WP_ENDOTHELIN_PATHWAYS,13,Down,0.778337612706955,0.96233780102094
665,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.778709051281566,0.96233780102094
666,WP_LUNG_PATHOLOGY_OF_COVID19,16,Up,0.781934983193783,0.96233780102094
667,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.781972416962326,0.96233780102094
668,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.782920961198527,0.96233780102094
669,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Up,0.783216531487845,0.96233780102094
670,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.785792271866664,0.963243699906808
671,WP_PEPTIDE_GPCRS,15,Up,0.786297472794974,0.963243699906808
672,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.787608872941219,0.963379743064134
673,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.788752514698494,0.963379743064134
674,WP_5Q35_COPY_NUMBER_VARIATION,76,Down,0.793028553276373,0.966921972318229
675,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.795278599900566,0.966921972318229
676,WP_IRINOTECAN_PATHWAY,5,Up,0.795458285997487,0.966921972318229
677,WP_APOPTOSIS,72,Up,0.797344500369699,0.966921972318229
678,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Down,0.79873207343265,0.966921972318229
679,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.799616048191092,0.966921972318229
680,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.800096482510152,0.966921972318229
681,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.801604721393882,0.966921972318229
682,WP_CAMKK2_PATHWAY,29,Up,0.802401502459174,0.966921972318229
683,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.803415702060037,0.966921972318229
684,WP_ALSTROM_SYNDROME,27,Down,0.805167688376228,0.967613800943362
685,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.808950354077874,0.970740424893448
686,WP_PI3KAKT_SIGNALING,180,Down,0.812207051059469,0.972970866186552
687,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.813817915537468,0.972970866186552
688,WP_IL5_SIGNALING,37,Up,0.815900778475967,0.972970866186552
689,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Up,0.816132476124981,0.972970866186552
690,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Up,0.816727369426668,0.972970866186552
691,WP_ERBB_SIGNALING,67,Up,0.820097447240374,0.975571782390141
692,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.821598667022051,0.975634364274023
693,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.824351408519821,0.975634364274023
694,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.826405465910821,0.975634364274023
695,WP_IL4_SIGNALING,50,Up,0.827167891007439,0.975634364274023
696,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.827371594136019,0.975634364274023
697,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.834859155087864,0.975634364274023
698,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.835070044597348,0.975634364274023
699,WP_NEUROINFLAMMATION,10,Up,0.835139912050113,0.975634364274023
700,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.835644389920713,0.975634364274023
701,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,78,Down,0.836547824059076,0.975634364274023
702,WP_IL19_SIGNALING,20,Up,0.837664789719572,0.975634364274023
703,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.839880368328698,0.975634364274023
704,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,17,Down,0.843166889694491,0.975634364274023
705,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.843796619477992,0.975634364274023
706,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.844776559456247,0.975634364274023
707,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.844883529367637,0.975634364274023
708,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.845515539060717,0.975634364274023
709,WP_GPCRS_OTHER,14,Up,0.84568263294349,0.975634364274023
710,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.850160015324013,0.975634364274023
711,WP_HYPERTROPHY_MODEL,14,Down,0.851042400512861,0.975634364274023
712,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.853359209685327,0.975634364274023
713,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.853884682698221,0.975634364274023
714,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Down,0.858140566842531,0.975634364274023
715,WP_ATM_SIGNALING,34,Down,0.858219483609617,0.975634364274023
716,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.858457850873599,0.975634364274023
717,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.858499065821064,0.975634364274023
718,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.859410650201844,0.975634364274023
719,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Up,0.859469346582015,0.975634364274023
720,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.859508433791802,0.975634364274023
721,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.859511485803076,0.975634364274023
722,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.86024529421953,0.975634364274023
723,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.861281266858035,0.975634364274023
724,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.861771575938174,0.975634364274023
725,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Up,0.862699419489782,0.975634364274023
726,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.863670100103388,0.975634364274023
727,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.864324252461109,0.975634364274023
728,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.864754413437876,0.975634364274023
729,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.866257456659768,0.975634364274023
730,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.866512403658841,0.975634364274023
731,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.868296779833206,0.975634364274023
732,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.87062583322888,0.975634364274023
733,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Up,0.870834546305587,0.975634364274023
734,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.876892638187101,0.975634364274023
735,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.877604340155308,0.975634364274023
736,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.879973840064227,0.975634364274023
737,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.881391104759383,0.975634364274023
738,WP_VITAMIN_B12_METABOLISM,27,Down,0.881915214751241,0.975634364274023
739,WP_PROLACTIN_SIGNALING,69,Up,0.883218984559842,0.975634364274023
740,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,142,Up,0.884052316629457,0.975634364274023
741,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.88613763292811,0.975634364274023
742,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.888405502784039,0.975634364274023
743,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.889620653103304,0.975634364274023
744,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.889749415703425,0.975634364274023
745,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.890666772594965,0.975634364274023
746,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,72,Up,0.891839581096593,0.975634364274023
747,WP_MAPK_CASCADE,30,Down,0.892197303222282,0.975634364274023
748,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.893698781805095,0.975634364274023
749,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,127,Down,0.894759769211195,0.975634364274023
750,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.894879790481359,0.975634364274023
751,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.896053678241835,0.975634364274023
752,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.896181048129236,0.975634364274023
753,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,66,Down,0.898185231638402,0.975634364274023
754,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.898623946519027,0.975634364274023
755,WP_PDGFRBETA_PATHWAY,27,Up,0.900341977698026,0.975634364274023
756,WP_PPAR_SIGNALING,39,Down,0.901358194888373,0.975634364274023
757,WP_AXON_GUIDANCE,37,Down,0.904308491844527,0.975634364274023
758,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.904631677381712,0.975634364274023
759,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Up,0.90663558940641,0.975634364274023
760,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.908369333879768,0.975634364274023
761,WP_IL2_SIGNALING,37,Up,0.908983142736965,0.975634364274023
762,WP_NAD_METABOLISM,12,Up,0.909598289094009,0.975634364274023
763,WP_POSTCOVID_NEUROINFLAMMATION,13,Up,0.910795610933197,0.975634364274023
764,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Up,0.911286769484979,0.975634364274023
765,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.91161022041702,0.975634364274023
766,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.912092114898979,0.975634364274023
767,WP_SMALL_CELL_LUNG_CANCER,71,Down,0.913205106726576,0.975634364274023
768,WP_AUTOPHAGY,27,Down,0.913670943470716,0.975634364274023
769,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.915331246540175,0.975634364274023
770,WP_COPPER_HOMEOSTASIS,40,Down,0.916170028961075,0.975634364274023
771,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.916760894172077,0.975634364274023
772,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Up,0.917990835477087,0.975634364274023
773,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.918174671341057,0.975634364274023
774,WP_AMINO_ACID_METABOLISM,59,Down,0.918663014535393,0.975634364274023
775,WP_EICOSANOID_SYNTHESIS,13,Down,0.924805388196674,0.98089036012602
776,WP_SYNAPTIC_VESICLE_PATHWAY,20,Up,0.926047627033955,0.980942202863287
777,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.927972409167128,0.981715984987618
778,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.930942275196732,0.983591966853102
779,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.932542859851533,0.984018268033325
780,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.93568487852231,0.984978181351535
781,WP_CELLULAR_PROTEOSTASIS,6,Down,0.936725589726224,0.984978181351535
782,WP_CHOLESTASIS,9,Down,0.937967625869141,0.984978181351535
783,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.938743866086888,0.984978181351535
784,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Up,0.940507128244022,0.984978181351535
785,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.94143908738854,0.984978181351535
786,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.941840450781394,0.984978181351535
787,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.943238294297862,0.985186630130677
788,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.947651703472236,0.988540228748957
789,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.950819357231668,0.990072788021059
790,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.952888111364342,0.990072788021059
791,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.953700384445137,0.990072788021059
792,WP_NEPHROTIC_SYNDROME,28,Down,0.953938744662626,0.990072788021059
793,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.962404777904844,0.996725848414292
794,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.962774116351518,0.996725848414292
795,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.964459607524664,0.997214839478332
796,WP_TRANSSULFURATION_PATHWAY,8,Up,0.966539001639281,0.997407103191776
797,WP_NRF2_PATHWAY,73,Down,0.967668907376588,0.997407103191776
798,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.968285727916104,0.997407103191776
799,WP_BURN_WOUND_HEALING,60,Down,0.969556921902803,0.997466570468216
800,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.970829259862657,0.99752706450888
801,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.973663984901761,0.998466994455376
802,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.974984919092004,0.998466994455376
803,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.976859918582793,0.998466994455376
804,WP_PLEURAL_MESOTHELIOMA,257,Up,0.9769279504641,0.998466994455376
805,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.977889006357367,0.998466994455376
806,WP_BLADDER_CANCER,29,Up,0.979271439562602,0.998466994455376
807,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Up,0.983734813274576,0.998466994455376
808,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.98606705938138,0.998466994455376
809,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.989751200313841,0.998466994455376
810,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.99147534313994,0.998466994455376
811,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.991891411621478,0.998466994455376
812,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.991944001166976,0.998466994455376
813,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.992082981973455,0.998466994455376
814,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.992922657173354,0.998466994455376
815,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Up,0.99404040902086,0.998466994455376
816,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.994123130873992,0.998466994455376
817,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.994123130873992,0.998466994455376
818,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.994238472856386,0.998466994455376
819,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.994822954329626,0.998466994455376
820,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,96,Up,0.996359471282814,0.998789616334723
821,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.99966074644716,0.99979827617214
822,WP_ESTROGEN_SIGNALING,21,Down,0.99979827617214,0.99979827617214
